These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21367930)

  • 1. The effect of insulin feedback on closed loop glucose control.
    Steil GM; Palerm CC; Kurtz N; Voskanyan G; Roy A; Paz S; Kandeel FR
    J Clin Endocrinol Metab; 2011 May; 96(5):1402-8. PubMed ID: 21367930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.
    Clarke WL; Anderson S; Breton M; Patek S; Kashmer L; Kovatchev B
    J Diabetes Sci Technol; 2009 Sep; 3(5):1031-8. PubMed ID: 20144416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The identifiable virtual patient model: comparison of simulation and clinical closed-loop study results.
    Kanderian SS; Weinzimer SA; Steil GM
    J Diabetes Sci Technol; 2012 Mar; 6(2):371-9. PubMed ID: 22538149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivariable adaptive closed-loop control of an artificial pancreas without meal and activity announcement.
    Turksoy K; Bayrak ES; Quinn L; Littlejohn E; Cinar A
    Diabetes Technol Ther; 2013 May; 15(5):386-400. PubMed ID: 23544672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies.
    Hovorka R; Kumareswaran K; Harris J; Allen JM; Elleri D; Xing D; Kollman C; Nodale M; Murphy HR; Dunger DB; Amiel SA; Heller SR; Wilinska ME; Evans ML
    BMJ; 2011 Apr; 342():d1855. PubMed ID: 21493665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of closed-loop insulin delivery in type 2 diabetes: a randomized controlled study.
    Kumareswaran K; Thabit H; Leelarathna L; Caldwell K; Elleri D; Allen JM; Nodale M; Wilinska ME; Evans ML; Hovorka R
    Diabetes Care; 2014; 37(5):1198-203. PubMed ID: 24026542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-breakfast closed-loop glucose control is improved when accompanied with carbohydrate-matching bolus compared to weight-dependent bolus.
    Haidar A; Farid D; St-Yves A; Messier V; Chen V; Xing D; Brazeau AS; Duval C; Boulet B; Legault L; Rabasa-Lhoret R
    Diabetes Metab; 2014 Jun; 40(3):211-4. PubMed ID: 24656963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites.
    Zisser H; Renard E; Kovatchev B; Cobelli C; Avogaro A; Nimri R; Magni L; Buckingham BA; Chase HP; Doyle FJ; Lum J; Calhoun P; Kollman C; Dassau E; Farret A; Place J; Breton M; Anderson SM; Dalla Man C; Del Favero S; Bruttomesso D; Filippi A; Scotton R; Phillip M; Atlas E; Muller I; Miller S; Toffanin C; Raimondo DM; De Nicolao G; Beck RW;
    Diabetes Technol Ther; 2014 Oct; 16(10):613-22. PubMed ID: 25003311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of intraday metabolic profiles during closed-loop glucose control in individuals with type 1 diabetes.
    Kanderian SS; Weinzimer S; Voskanyan G; Steil GM
    J Diabetes Sci Technol; 2009 Sep; 3(5):1047-57. PubMed ID: 20144418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.
    Haidar A; Legault L; Dallaire M; Alkhateeb A; Coriati A; Messier V; Cheng P; Millette M; Boulet B; Rabasa-Lhoret R
    CMAJ; 2013 Mar; 185(4):297-305. PubMed ID: 23359039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated hybrid closed-loop control with a proportional-integral-derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance.
    Ly TT; Weinzimer SA; Maahs DM; Sherr JL; Roy A; Grosman B; Cantwell M; Kurtz N; Carria L; Messer L; von Eyben R; Buckingham BA
    Pediatr Diabetes; 2017 Aug; 18(5):348-355. PubMed ID: 27191182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical update on optimal prandial insulin dosing using a refined run-to-run control algorithm.
    Zisser H; Palerm CC; Bevier WC; Doyle FJ; Jovanovic L
    J Diabetes Sci Technol; 2009 May; 3(3):487-91. PubMed ID: 20144286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of insulin feedback on closed-loop glucose control: a crossover study.
    Ruiz JL; Sherr JL; Cengiz E; Carria L; Roy A; Voskanyan G; Tamborlane WV; Weinzimer SA
    J Diabetes Sci Technol; 2012 Sep; 6(5):1123-30. PubMed ID: 23063039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial.
    Stewart ZA; Wilinska ME; Hartnell S; O'Neil LK; Rayman G; Scott EM; Barnard K; Farrington C; Hovorka R; Murphy HR
    Diabetes Care; 2018 Jul; 41(7):1391-1399. PubMed ID: 29535135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postprandial glycemic excursions with the use of a closed-loop platform in subjects with type 1 diabetes: a pilot study.
    van Bon AC; Hermanides J; Koops R; Hoekstra JB; DeVries JH
    J Diabetes Sci Technol; 2010 Jul; 4(4):923-8. PubMed ID: 20663458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial.
    Elleri D; Allen JM; Kumareswaran K; Leelarathna L; Nodale M; Caldwell K; Cheng P; Kollman C; Haidar A; Murphy HR; Wilinska ME; Acerini CL; Dunger DB; Hovorka R
    Diabetes Care; 2013 Apr; 36(4):838-44. PubMed ID: 23193217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes.
    Murphy HR; Elleri D; Allen JM; Harris J; Simmons D; Rayman G; Temple R; Dunger DB; Haidar A; Nodale M; Wilinska ME; Hovorka R
    Diabetes Care; 2011 Feb; 34(2):406-11. PubMed ID: 21216859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.
    Rossetti P; Quirós C; Moscardó V; Comas A; Giménez M; Ampudia-Blasco FJ; León F; Montaser E; Conget I; Bondia J; Vehí J
    Diabetes Technol Ther; 2017 Jun; 19(6):355-362. PubMed ID: 28459603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.